Skip to search.
 FTSE 100 Down 1.32%

More On PTIX

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Protagenic Therapeutics, Inc. (PTIX)

-Other OTC
0.00 0.00(0.00%) N/A
Prev Close:0.00
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.50
Beta:-21.6866
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.81 - 4.23
Volume:6
Avg Vol (3m):N/A
Market Cap:12.92
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for PTIX at this time.

Comparison

Symbol% ChgMkt Cap
PTIX 0.00%12.92
RSYSDown 1.78%211.69m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protagenic Therapeutics, Inc., a biotechnology company, discovers, researches, and develops human neuropeptide-based brain- active therapeutics for treatment of depression, mood, anxiety, and neurodegenerative disorders. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback